CO6491119A2 - Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo - Google Patents

Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo

Info

Publication number
CO6491119A2
CO6491119A2 CO12020130A CO12020130A CO6491119A2 CO 6491119 A2 CO6491119 A2 CO 6491119A2 CO 12020130 A CO12020130 A CO 12020130A CO 12020130 A CO12020130 A CO 12020130A CO 6491119 A2 CO6491119 A2 CO 6491119A2
Authority
CO
Colombia
Prior art keywords
cell culture
cell
culture system
polypeptide
interest
Prior art date
Application number
CO12020130A
Other languages
English (en)
Spanish (es)
Inventor
Leopold Grillberger
Manfred Reiter
Daniel Fleischanderl
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of CO6491119A2 publication Critical patent/CO6491119A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CO12020130A 2009-07-31 2012-02-06 Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo CO6491119A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31

Publications (1)

Publication Number Publication Date
CO6491119A2 true CO6491119A2 (es) 2012-07-31

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12020130A CO6491119A2 (es) 2009-07-31 2012-02-06 Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo

Country Status (22)

Country Link
US (4) US8580554B2 (enExample)
EP (2) EP2459697B1 (enExample)
JP (2) JP5808742B2 (enExample)
KR (2) KR101885046B1 (enExample)
CN (1) CN102549142B (enExample)
AU (1) AU2010277490B2 (enExample)
BR (1) BR112012002137B8 (enExample)
CA (1) CA2769354A1 (enExample)
CO (1) CO6491119A2 (enExample)
DK (1) DK2459697T3 (enExample)
EA (1) EA022219B1 (enExample)
ES (1) ES2705206T3 (enExample)
HR (1) HRP20182165T1 (enExample)
IN (1) IN2012DN00899A (enExample)
MX (2) MX2012001274A (enExample)
NZ (1) NZ597742A (enExample)
PL (1) PL2459697T3 (enExample)
PT (1) PT2459697T (enExample)
SG (1) SG178176A1 (enExample)
SI (1) SI2459697T1 (enExample)
TR (1) TR201900213T4 (enExample)
WO (1) WO2011012725A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3037386T3 (en) 2010-07-08 2025-10-01 Takeda Pharmaceuticals Co Method of producing recombinant high molecular weight vwf in cell culture
ES2890412T3 (es) * 2011-01-17 2022-01-19 Hoffmann La Roche Aparato de separación
KR101980164B1 (ko) 2011-05-13 2019-05-20 옥타파마 아게 재조합 fviii의 생산에서 진핵 세포의 생산성을 증가시키는 방법
HUE033279T2 (en) 2011-07-01 2017-11-28 Amgen Inc Mammalian cell culture
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
ES2663815T3 (es) 2011-11-24 2018-04-17 Genethon Sistema de producción de un vector lentiviral escalable compatible con aplicaciones farmacéuticas industriales
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
HK1219964A1 (zh) 2013-03-08 2017-04-21 Genzyme Corporation 治疗性蛋白药物物质的整合连续制造
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014146933A1 (en) * 2013-03-19 2014-09-25 Cmc Biologics A/S A method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process.
US10392603B2 (en) * 2013-08-30 2019-08-27 The Chemo-Sero-Therapeutic Research Institute Method of viral purification
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
AU2015240354A1 (en) 2014-04-01 2016-11-17 Advantech Bioscience Farmaceutica Ltda. Stabilization of Factor VIII without calcium as an excipient
MX2016012870A (es) 2014-04-01 2017-05-12 Advantech Bioscience Farmacêutica Ltda Formulaciones de factor viii estables con bajo tenor de azucar - glicina.
EP3158055B1 (en) * 2014-06-13 2019-09-11 CSL Limited Improved production of recombinant von willebrand factor in a bioreactor
KR20240173213A (ko) 2016-01-26 2024-12-10 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
SG11201809051YA (en) * 2016-04-15 2018-11-29 Boehringer Ingelheim Int Cell retention device and method
JP7408389B2 (ja) * 2016-12-21 2024-01-05 エフ. ホフマン-ラ ロシュ アーゲー 真核細胞の増殖制御方法
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
AU2019332764B2 (en) 2018-08-31 2025-05-29 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
AU2001291653A1 (en) 2000-10-02 2002-04-15 Novo-Nordisk A/S Industrial-scale serum-free production of recombinant factor vii in mammalian cells
IL161858A0 (en) * 2001-11-28 2005-11-20 Sandoz Ag Cell culture process
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
AU2006257073B2 (en) 2005-06-17 2011-08-04 Children's Medical Center Corporation ADAMTS13-comprising compositions having thrombolytic activity
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
PL2235197T3 (pl) * 2007-12-27 2018-01-31 Baxalta GmbH Sposoby hodowli komórek

Also Published As

Publication number Publication date
HRP20182165T1 (hr) 2019-03-08
TR201900213T4 (tr) 2019-02-21
SG178176A1 (en) 2012-03-29
AU2010277490B2 (en) 2014-08-28
JP2013500710A (ja) 2013-01-10
NZ597742A (en) 2014-02-28
US20140038264A1 (en) 2014-02-06
US10221400B2 (en) 2019-03-05
AU2010277490A1 (en) 2012-02-09
EP2459697A1 (en) 2012-06-06
KR101885046B1 (ko) 2018-08-02
US10745672B2 (en) 2020-08-18
US8580554B2 (en) 2013-11-12
JP2015062436A (ja) 2015-04-09
MX353610B (es) 2018-01-18
WO2011012725A1 (en) 2011-02-03
US9650612B2 (en) 2017-05-16
SI2459697T1 (sl) 2019-03-29
IN2012DN00899A (enExample) 2015-04-03
BR112012002137B8 (pt) 2020-05-12
BR112012002137A2 (pt) 2015-09-15
MX2012001274A (es) 2012-06-01
JP6177260B2 (ja) 2017-08-09
PT2459697T (pt) 2019-01-21
US20190153400A1 (en) 2019-05-23
ES2705206T3 (es) 2019-03-22
JP5808742B2 (ja) 2015-11-10
EA201270213A1 (ru) 2012-06-29
KR20170077286A (ko) 2017-07-05
CN102549142B (zh) 2014-07-16
EP2459697B1 (en) 2018-10-17
EP3480292A1 (en) 2019-05-08
WO2011012725A8 (en) 2011-05-05
PL2459697T3 (pl) 2019-04-30
US20110086411A1 (en) 2011-04-14
DK2459697T3 (en) 2019-01-28
EA022219B1 (ru) 2015-11-30
US20180051261A1 (en) 2018-02-22
CA2769354A1 (en) 2011-02-03
BR112012002137B1 (pt) 2020-04-14
CN102549142A (zh) 2012-07-04
KR20120038531A (ko) 2012-04-23
KR101752789B1 (ko) 2017-06-30

Similar Documents

Publication Publication Date Title
CO6491119A2 (es) Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo
ES2527173T3 (es) Células de fucosilación deficiente
AR132549A2 (es) Medio de cultivo para células cho libre de suero que comprende ornitina y putrescina, método para cultivar células cho y método in vitro para producir una proteína
AR111785A2 (es) Método in vitro de producción de eritrocitos
Gjoerup et al. Update on human polyomaviruses and cancer
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
AR095354A1 (es) Métodos para el armado de bancos celulares de alta densidad
NZ601424A (en) Method for the production of ad26 adenoviral vectors
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
CO6680636A2 (es) Método para producir adamts13 recombinante en cultivo celular
BR112022017216A2 (pt) Método para produzir células exterminadoras naturais a partir de células-tronco pluripotentes
MX340242B (es) Proceso mejorado para el cultivo de celulas.
JP2015532096A5 (enExample)
BR112012030266A2 (pt) processo para fermentação acelerada e dispositivo para mistura do conteúdo de um tanque
BR112015007319A2 (pt) composições e métodos para produzir glicoproteínas
BR112022021613A2 (pt) Métodos para gerar células tímicas in vitro
Umrath et al. Generation of iPSCs from jaw periosteal cells using self-replicating RNA
Srinivasan et al. Effects of cryogenic storage on human amnion epithelial cells
BR112013028006A2 (pt) método para aumentar a produtividade de células eucarióticas na produção do recombinante fviii
MX2020013633A (es) Metodos para producir proteinas recombinantes.
CL2013002723A1 (es) Metodo de produccion de una particula semejante a virus (vlp) de alfavirus salmonido (sav) en celulas de insecto.
AR085271A1 (es) Procedimiento para la produccion a escala comercial de prrsv
BRPI0914805B8 (pt) método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição
BR112017017303B8 (pt) Método para obtenção de clones de células de alta produtividade
BRPI0417775A (pt) meio de congelamento de células livre de soro; processo para gerar um banco de células vero estável livre de soro; e banco de célula vero estável livre de soro